Ann: MedAdvisor Quarterly Report & Appendix 4C, page-9

  1. 343 Posts.
    lightbulb Created with Sketch. 3
    They really to address the following:
    - How is the roll out of PlusOne going? What has bee the feedback from customers? How will this drive increased profitability?
    - What are the monetisation plans for tap-to-refill?
    - What are the plans for monetisation of sales/dispensing data that will be available from pharmacies once PlusOne is in place? NostraData (A player in this field) is listed as a related party in the Prospectus. How are these companies working together.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $50.02M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $44.53K 558.3K

Buyers (Bids)

No. Vol. Price($)
1 12658 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 84920 2
View Market Depth
Last trade - 14.07pm 25/07/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.